Huma Dar

About me

Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(35):4071-4082

Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial.

Johansson A; Dar H; van 't Veer LJ; Tobin NP; Perez-Tenorio G; Nordenskjöld A; Johansson U; Hartman J; Skoog L; Yau C; Benz CC; Esserman LJ; Stål O; Nordenskjöld B; Fornander T; Lindström LS
Article: JAMA NETWORK OPEN. 2021;4(6):e2114904

Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.

Dar H; Johansson A; Nordenskjöld A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjöld B; Stål O; Esserman LJ; Fornander T; Lindström LS
Article: INTERNATIONAL JOURNAL OF CANCER. 2016;139(11):2415-2425

Worse quality of life in young and recently diagnosed breast cancer survivors compared with female survivors of other cancers: A cross-sectional study.

Li J; Humphreys K; Eriksson M; Dar H; Brandberg Y; Hall P; Czene K

Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2024-2025

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2023
Degree Of Master Of Medical Science 120 Credits, Karolinska Institutet, 2015